Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
featured
  • 74 views
  • 08 Nov, 2020
  • 1 location
Veliparib Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

This phase II trial studies how well veliparib, radiation therapy, and temozolomide work in treating patients with newly diagnosed malignant glioma without H3 K27M or BRAFV600 mutations. Poly

immunohistochemistry
glioblastoma multiforme
blood transfusion
astrocytoma
astrocytoma, anaplastic
  • 403 views
  • 01 Aug, 2021
  • 112 locations
Pre-Operative Radiation and Veliparib for Breast Cancer

The investigators' primary aim is to determine the safety, tolerability and maximum tolerated dose (within 50 - 200mg/BID dose range) when combining veliparib and radiation. The

carcinoma
mastectomy
triple negative breast cancer
metastasis
lumpectomy
  • 13 views
  • 22 Jul, 2021
  • 6 locations
Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

This phase I trial studies the side effects and the best dose of veliparib and dinaciclib in treating patients with solid tumors that have spread to other places in the body and usually cannot

international normalized ratio
kinase inhibitor
veliparib
solid tumour
parp inhibitor
  • 5 views
  • 31 Jul, 2021
  • 2 locations